Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: A meta-analysis of randomised controlled trials

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Briel, Matthias ^a   Boscacci, Remy ^b   Furrer, Hansjakob ^b   Bucher, Heiner C ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE; TRIMETHOPRIM; CORTICOSTEROID;

ARTERIAL OXYGEN TENSION; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; EMBASE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXEMIA; LUNG ALVEOLUS OXYGEN TENSION; MEDLINE; META ANALYSIS; MORTALITY; PNEUMOCYSTIS PNEUMONIA; RANDOMIZATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ARTICLE; MICROBIOLOGY; PNEUMOCYSTIS JIROVECI; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK;

ADRENAL CORTEX HORMONES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MEDLINE; ODDS RATIO; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RISK;

EID: 27944449680     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-101     Document Type: Review

References (25)

1. Stringer JR, Beard CB, Miller RF, Wakefield AE: A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002, 8: 891-896.
2. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL: Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000, 30 Suppl 1: S5-14.
3. Randall CJ, Yarnold PR, Schwartz DN, Weinstein RA, Bennett CL: Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2000, 162: 393-398.
4. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. N Engl J Med 1990, 323: 1500-1504.
5. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK: Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recomm Rep 2004, 53: 1-112.
6. Nielsen TL, Eeftinck Schattenkerk JK, Jensen BN, Lundgren JD, Gerstoft J, van Steenwijk RP, Bentsen K, Frissen PH, Gaub J, Orholm M, Hansen J, Mathiesen L, Skinhoj P, Danner SA, Nielsen JO: Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study. J Acquir Immune Defic Syndr 1992, 5: 726-731.
7. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L: Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med 1990, 323: 1444-1450.
8. Montaner JS, Lawson LM, Levitt N, Belzberg A, Schechter MT, Ruedy J: Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990, 113: 14-20.
9. Clement M, Edison R, Turner J, Montgomery B, Luce J, Feigal D, Hopewell P: Corticosteroids as adjunctive therapy in severe Pneumocystis carinii pneumonia: a prospective placebo-controlled trial. Am Rev Respir Dis 1989, 139: A250 (abstract).
10. Sistek CJ, Wordell CJ, Hauptman SP: Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients. Ann Pharmacother 1992, 26: 1127-1133.
11. Juni P, Witschi A, Bloch R, Egger M: The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999, 282: 1054-1060.
12. Sterne JA, Egger M, Smith GD: Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001, 323: 101-105.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003, 327: 557-560.
14. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21: 1539-1558.
15. Marx A, Bucher HC: Numbers needed to treat derived from meta-analysis: a word of caution. ACP J Club 2003, 138: A11-A12.
16. Bozzette SA, Sattler FR, Chiu J, Wu AW, Gluckstein D, Kemper C, Bartok A, Niosi J, Abramson I, Coffman J, Hughlett C, Loya R, Cassens B, Akil B, Meng T, Boylen CT, Nielsen D, Richman DD, Tilles JG, Leedom J, McCutchen JA: A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1990, 323: 1451-1457.
17. Jeantils V, Nguyen G, Bacle F, Thomas M: Adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in AIDS. Therapie 1993, 48: 70-71.
18. Montaner JS, Guillemi S, Quieffin J, Lawson L, Le T, O'Shaughnessy M, Ruedy J, Schechter MT: Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS). Tuber Lung Dis 1993, 74: 173-179.
19. Walmsley S, Levinton C, Brunton J, Muradali D, Rappaport D, Bast M, Spence D, Salit I: A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8: 348-357.
20. Fisk DT, Meshnick S, Kazanjian PH: Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 2003, 36: 70-78.
21. Sepkowitz KA: Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002, 34: 1098-1107.
22. Lambertus MW, Goetz MB, Murthy AR, Mathisen GE: Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Chest 1990, 98: 38-43.
23. Nelson MR, Erskine D, Hawkins DA, Gazzard BG: Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 1993, 7: 375-378.
24. Gallant JE, Chaisson RE, Moore RD: The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest 1998, 114: 1258-1263.
25. Pareja JG, Garland R, Koziel H: Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998, 113: 1215-1224.